Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;21(9):922-8.
doi: 10.1016/j.semcdb.2010.08.008. Epub 2010 Sep 9.

Nrg1/ErbB signaling networks in Schwann cell development and myelination

Affiliations
Review

Nrg1/ErbB signaling networks in Schwann cell development and myelination

Jason Newbern et al. Semin Cell Dev Biol. 2010 Dec.

Abstract

Neuregulin-1 (Nrg1) provides a key axonal signal that regulates Schwann cell proliferation, migration and myelination through binding to ErbB2/3 receptors. The analysis of a number of genetic models has unmasked fundamental mechanisms underlying the specificity of the Nrg1/ErbB signaling axis. Differential expression of Nrg1 isoforms, Nrg1 processing, and ErbB receptor localization and trafficking represent important regulatory themes in the control of Nrg1/ErbB function. Nrg1 binding to ErbB2/3 receptors results in the activation of intracellular signal transduction pathways that initiate changes in Schwann cell behavior. Here, we review data that has defined the role of key Nrg1/ErbB signaling components like Shp2, ERK1/2, FAK, Rac1/Cdc42 and calcineurin in development of the Schwann cell lineage in vivo. Many of these regulators receive converging signals from other cues that are provided by Notch, integrin or G-protein coupled receptors. Signaling by multiple extracellular factors may act as key modifiers and allow Schwann cells at different developmental stages to respond in distinct manners to the Nrg1/ErbB signal.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Nrg1/ErbB signaling
Following Nrg1 binding, heteromeric ErbB2/3 receptors auto- and trans-phosphorylate specific tyrosine residues, and to these phosphorylated residues specific adaptor proteins and enzymes are recruited. This results in the activation of a number of downstream signaling pathways, including PI3K/Akt, Erk1/2, FAK, and Rac/Cdc42, and Ca2+ regulated pathways downstream of PLCγ lead to activation of calcineurin. Shp2 and Src are thought to regulate Erk1/2 signaling by modulating Ras, although other mechanisms also have been observed. These pathways regulate the activity of cytoplasmic and nuclear signal transduction molecules that mediate specific Schwann cell responses to the Nrg1 signal.
Figure 2
Figure 2. Hypomyelination of ErbB2 and Shp2 mutant peripheral nerves
Electron microscopic analysis of peripheral nerves from control mice (A), and from mice that carry Schwann cell-specific mutations of ErbB2 (B) or Shp2 (C) that were introduced using a Krox20cre allele. Note that the conditional ErbB2 and Shp2 mutant mice display a marked hypomyelination in the adult. (D) Quantification of myelin thickness in adult control (blue bars), conditional ErbB2 (red bars) and Shp2 (yellow bars) mutant mice. Displayed is a plot of the myelin thickness versus axon diameter. Note the similarity of the effects of the ErbB2 and Shp2 mutations.
Figure 3
Figure 3
Nrg1/ErbB signaling acts cooperatively with other extracellular cues to control myelination. Amongst many potentially important ligand/receptor complexes, key roles have been attributed to laminin/integrin and Gpr126 signaling in Schwann cell myelination in vivo.

References

    1. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature. 1986;319(6050):226–30. - PubMed
    1. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984;307(5951):521–7. - PubMed
    1. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, et al. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest. 2007;117(8):2051–8. - PMC - PubMed
    1. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2(2):127–37. - PubMed
    1. Burgess AW, Cho HS, Eigenbrot C, Ferguson KM, Garrett TP, Leahy DJ, et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell. 2003;12(3):541–52. - PubMed

Publication types